Co Diagnostics earnings were -$48.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CODX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$9.1M, down 64.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CODX reported annual earnings of -$46.9M, with 24.6% growth. The next CODX earnings date is Aug 13, 2026.
Co Diagnostics (NASDAQ: CODX) reported Q1 2026 earnings per share (EPS) of -$4.06, up 42.41% year over year. Total CODX earnings for the quarter were -$9.14 million. In the same quarter last year, Co Diagnostics's earnings per share (EPS) was -$7.05.
The next CODX earnings date is Invalid Date. Add CODX to your watchlist to be reminded of Co Diagnostics's next earnings date.
What was CODX's earnings growth in the past year?
As of Co Diagnostics's earnings date in Q3 2026, Co Diagnostics's earnings has grown year over year. CODX earnings in the past year totalled -$48.50 million.
Is Co Diagnostics profitable or losing money?
As of the last Co Diagnostics earnings report, Co Diagnostics is currently losing money. Co Diagnostics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$48.50 million, a 35.25% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.